These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2993348)

  • 1. Thyrotropin receptor-adenylate cyclase system in Hurthle cell neoplasms.
    Clark OH; Gerend PL
    J Clin Endocrinol Metab; 1985 Oct; 61(4):773-8. PubMed ID: 2993348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the thyrotropin receptor-adenylate cyclase system in neoplastic human thyroid tissue.
    Clark OH; Gerend PL; Goretzki P; Nissenson RA
    J Clin Endocrinol Metab; 1983 Jul; 57(1):140-7. PubMed ID: 6304132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyrotropin binding and adenylate cyclase activation in normal and neoplastic human thyroid tissue: lack of effect of thyroglobulin.
    Clark OH; Gerend PL; Nissenson RA
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1157-63. PubMed ID: 7076796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyrotropin (TSH) receptor and adenylate cyclase activity in human thyroid tumors: absence of high affinity receptor and loss of TSH responsiveness in undifferentiated thyroid carcinoma.
    Abe Y; Ichikawa Y; Muraki T; Ito K; Homma M
    J Clin Endocrinol Metab; 1981 Jan; 52(1):23-8. PubMed ID: 6256403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyrotropin receptor-adenylate cyclase function in human thyroid neoplasms.
    Saltiel AR; Powel-Jones CH; Thomas CG; Nayfeh SN
    Cancer Res; 1981 Jun; 41(6):2360-5. PubMed ID: 6263464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyrotropin regulation of adenylate cyclase activity in human thyroid neoplasms.
    Clark OH; Gerend PL
    Surgery; 1985 May; 97(5):539-46. PubMed ID: 2986305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TSH binding correlates with TSH-stimulated thyroid adenylate cyclase activity in human thyroid tissues.
    Duh QY; Siperstein AE; Miller RA; Smeds S; Clark OH
    Surgery; 1989 Dec; 106(6):967-73; discussion 973-4. PubMed ID: 2588124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyrotropin binding and adenylate cyclase stimulation in thyroid neoplasms.
    Clark OH; Gerend PL; Cote TC; Nissenson RA
    Surgery; 1981 Aug; 90(2):252-61. PubMed ID: 6266060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relevance of the low and high affinity thyrotropin-binding sites of human thyroid membranes to the stimulation of adenylate cyclase.
    Lefort GP; Amr S; Carayon P; Nisula BC
    Endocrinology; 1984 Mar; 114(3):1005-11. PubMed ID: 6321134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive regulation of the guinea pig thyrotropin receptor.
    Davies TF
    Endocrinology; 1985 Jul; 117(1):201-7. PubMed ID: 2988915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The carbohydrate moiety of bovine thyrotropin is essential for full bioactivity but not for receptor recognition.
    Amir SM; Kubota K; Tramontano D; Ingbar SH; Keutmann HT
    Endocrinology; 1987 Jan; 120(1):345-52. PubMed ID: 3023032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of high-affinity binding sites for beta-adrenergic blockers and lack of adenyl cyclase stimulation to beta-adrenergic stimulators in most normal and adenomatous human thyroid tissues.
    Goretzki PE; Wahl RA; Branscheid D; Roeher HD
    Surgery; 1984 Dec; 96(6):1001-8. PubMed ID: 6150553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive activation of the Gs alpha protein-adenylate cyclase pathway may not be sufficient to generate toxic thyroid adenomas.
    Derwahl M; Hamacher C; Russo D; Broecker M; Manole D; Schatz H; Kopp P; Filetti S
    J Clin Endocrinol Metab; 1996 May; 81(5):1898-904. PubMed ID: 8626855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulatory effect of vasoactive intestinal polypeptide on human normal and neoplastic thyroid tissue.
    Siperstein AE; Miller RA; Clark OH
    Surgery; 1988 Dec; 104(6):985-91. PubMed ID: 2848326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that partially desialylated variants of human chorionic gonadotropin (hCG) are the factors in crude hCG that inhibit the response to thyrotropin in human thyroid membranes.
    Hoermann R; Amir SM; Ingbar SH
    Endocrinology; 1988 Sep; 123(3):1535-43. PubMed ID: 3402396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by certain plant extracts of the binding and adenylate cyclase stimulatory effect of bovine thyrotropin in human thyroid membranes.
    Auf'mkolk M; Ingbar JC; Amir SM; Winterhoff H; Sourgens H; Hesch RD; Ingbar SH
    Endocrinology; 1984 Aug; 115(2):527-34. PubMed ID: 6745167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human thyroid cancer: membrane thyrotropin binding and adenylate cyclase activity.
    Carayon P; Thomas-Morvan C; Castanas E; Tubiana M
    J Clin Endocrinol Metab; 1980 Oct; 51(4):915-20. PubMed ID: 7419673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyphloretin phosphate, an antagonist of thyrotropin action: evidence for an interaction with the hormone rather than the receptor.
    Amir SM; Kasagi K; Corretti M; Blank M; Ingbar SH
    Endocrinology; 1985 Sep; 117(3):860-8. PubMed ID: 2990874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of thyroid adenylate cyclase: guanyl nucleotide modulation of thyrotropin receptor-adenylate cyclase function.
    Saltiel AR; Powell-Jones CH; Thomas CG; Nayfeh SN
    Endocrinology; 1981 Nov; 109(5):1578-89. PubMed ID: 6271536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activities of deglycosylated thyrotropin at the thyroid membrane receptor-adenylate cyclase system.
    Amr S; Menezez-Ferreira M; Shimohigashi Y; Chen HC; Nisula B; Weintraub BD
    J Endocrinol Invest; 1985 Dec; 8(6):537-41. PubMed ID: 3009595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.